All regulatory communications have data.
Successful communications have a story.
Work with 3D to get your story straight from the start.
Obtain critical recommendations from advisory panels for your MAA.
Communicate compelling arguments for key issues or questions.
Align with experts on recommendations favoring MAA approval.
Clarify key elements of your scientific narrative to the EMA-CHMP.
That’s where 3D comes in. 3D helps you
-
Establish clear messaging around complex scientific issues.
-
Create briefing materials, scripted presentations, and Q&A content.
-
Test content with external experts who mirror your anticipated audience.
We work with you to set the stage for regulatory success with positive recommendations from EMA-CHMP advisory groups.
AHEG = Ad Hoc Expert Group; PRAC = Pharmacovigilance Risk Assessment Committee; SAG = Scientific Advisory Group
Our Latest Thinking
- The Stakes Don’t Get Higher Than This: Racing Against the Virus to Help Moderna’s COVID-19 Vaccine Receive Emergency Use Authorization
- Rethinking A Biotech's Investor And Media Communications Strategy
- Op-Ed: Leading by Example on COVID Vax Won't Sway Black Community
Our proven process 3D ACT® is not magic. It's better.
Learn Why